MM-493 Efficacy and Safety of Idecabtagene Vicleucel (Ide-Cel) with Lenalidomide (R) Maintenance Versus R Maintenance Alone in Adult Patients with Newly Diagnosed Multiple Myeloma (NDMM) Who Have Suboptimal Response to Autologous Stem Cell Transplantation (ASCT): Phase 3 KarMMa-9 Trial
Clinical Lymphoma Myeloma and Leukemia(2024)
关键词
MM,CAR T-cell therapy,ide-cel,multiple myeloma,phase 3,clinical trial
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要